Oleg S. Gorbatyuk

Recombinant AAV Viral Vectors Pseudotyped with Viral Capsids from Serotypes 1, 2, and 5 Display Differential Efficiency and Cell Tropism after Delivery to Different Regions of the Central Nervous System

Corinna Bürger, Oleg S. Gorbatyuk, Margaret J. Velardo et al. · Molecular Therapy · 2004 · 738 citations · Full text

Life Sciences, Neurobiology, Neuroscience +13

The phosphorylation state of Ser-129 in human α-synuclein determines neurodegeneration in a rat model of Parkinson disease

Oleg S. Gorbatyuk, Shoudong Li, Layla F Sullivan et al. · Proceedings of the National Academy of Sciences · 2008 · 291 citations · Full text

Life Sciences, Neurobiology, Neuroscience +16

Restoration of visual function in P23H rhodopsin transgenic rats by gene delivery of BiP/Grp78

Marina S. Gorbatyuk, Tessa Knox, Matthew M. LaVail et al. · Proceedings of the National Academy of Sciences · 2010 · 288 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

In Vivo RNAi-Mediated α-Synuclein Silencing Induces Nigrostriatal Degeneration

Oleg S. Gorbatyuk, Shoudong Li, Kevin Nash et al. · Molecular Therapy · 2010 · 208 citations · Full text

Life Sciences, Molecular Biology, Neurobiology +17

Adeno-Associated Virus Type 2 VP2 Capsid Protein Is Nonessential and Can Tolerate Large Peptide Insertions at Its N Terminus

Kenneth H. Warrington, Oleg S. Gorbatyuk, Jeffrey K. Harrison et al. · Journal of Virology · 2004 · 205 citations · Full text

Life Sciences, Biology, Molecular Biology +17